Table Of Content

Clinical Endocrinology (2003) 59, 830-840 index Abalovich, M., Llesuy, S., Gutierrez, S. & Repetto, M. Peripheral Arp, P. see van Rossum, E.F.C. parameters of oxidative stress in Graves’ disease: the effects Arvat, E. see Gianotti, L. of methimazole and 131 iodine treatments: 321 Arvat, E. see Giordano, R. Adami, S. see Zoico, E. Asenbaum, S. see Zettinig, G. Agranovicz, S. see Krausz, Y. Assies, J., Haverkort, E.B., Lieverse, R. & Vreken, P. Effect of Agretti, P. see Tonacchera, M. dehydroepiandrosterone supplementation on fatty acid and Ahrén, B. see Biilow, B hormone levels in patients with X-linked adrenoleucodys- Aimaretti, G. see Popovic, V. trophy: 459 Aimaretti, G., Corneli, G., Baldelli, R., Di Somma, C., Astuti, D., Hart-Holden, N., Latif, F, Lalloo, F., Black, G.C., Gasco, V., Durante, C., Ausiello, L., Rovere, S., Grottoli, S., Lim, C., Moran, A., Grossman, A.B., Hodgson, S.V., Tamburrano, G. & Ghigo, E. Diagnostic reliability of a Freemont, A., Ramsden, R., Eng, C., Evans, D.G.R. & single IGF-I measurement in 237 adults with total anterior Maher, E.R. Genetic analysis of mitochondrial complex II hypopituitarism and severe GH deficiency: 56 subunits SDHD, SDHB and SDHC in paraganglioma and Akada, K. see Nishioka, H phaeochromocytoma susceptibility: 728 Alessi, E. see Verga, | Ausiello, L. see Aimaretti, G. Alevizaki, C.C. see Alevizaki, M Avila, A. see Bazaes, R.A. Alevizaki, M., Cimponeriu, A.T., Garofallaki, M., Sarika, H.-L., van Baar, A.L. see Pop, V.J Alevizaki, C.C., Papamichael, C., Philippou, G., Anastasiou, Badenhoop, K. & Seidl, C. Fine-tuning of T lymphocytes in E.A., Lekakis, J.P. & Mavrikakis, M. The androgen receptor autoimmunity: genetic association of CTLA-4 variants and gene CAG polymorphism is associated with the severity of Graves’ disease revisited: 555 coronary artery disease in men: 749 Balci, M.K. see Cakir, M. Altunbas, H. see Sari, R. Balci, M.K. see Sari, R Alvarez, P., Isidro, L., Peind, R., Leal-Cerro, A., Casanueva, F.F., Balci, N. see Cakir, M. Dieguez, C. & Cordido, F. Effect of acute reduction of free Baldelli, R. see Aimaretti, G. fatty acids by acipimox on growth hormone-releasing Baldelli, R., Battista, C., Leonetti, F, Ghiggi, M.-R., Ribaudo, hormone-induced GH secretion in type | diabetic patients M.-C., Paoloni, A., D’Amico, E., Ferretti, E., Baratta, R., 431 Liuzzi, A., Trischitta, V. & Tamburrano, G. Glucose home- Amato, G. see Mazziotti, G ostasis in acromegaly: effects of long-acting somatostatin Ambrogini, E. see Tonacchera, M. analogues treatment: 492 Anastasiou, E.A. see Alevizaki, M. Baratta, R. see Baldelli, R. de Andrés-Aguayo, I. see Webb, S.M Barbieri, F. see Florio, T. Antunes-Rodrigues, J. see Elias, P-C.L Bar-Shalom, R. see Krausz, Y Anyaoku, V. see Kousta, E. Battista, C. see Baldelli, R. Arai, K. see Kim, K Baudin, E. see Gussi, I.-L Arena, S. see Florio, T Bazaes, R.A., Petry, C.J., Ong, K.K., Avila, A., Dunger, D.B. & Arends, N.J.T., Boonstra, V.H., Mulder, P.G.H., Odink, R.J.H., Mericq, M.V. Insulin gene VNTR genotype is associated Stokvis-Brantsma, W.H., Rongen-Westerlaken, C., Mulder, with insulin sensitivity and secretion in infancy: 599 J.C., Delemarre-Van de Waal, H., Reeser, H.M., Jansen, M., Beckett, G.J. see Strachan, M.W.J. Waelkens, J.J.J. & Hokken-Koelega, A.C.S. GH treatment Beck-Peccoz, P. see Fugazzola, L. and its effect on bone mineral density, bone maturation and Beck-Peccoz, P. see Giavoli, C. growth in short children born small for gestational age: Beck-Peccoz, P. see Verga, U. 3-year results of a randomized, controlled GH trial: 779 Bednarczuk, T., Placha, G., Jazdzewski, K., Kurylowicz, A., Armitage, M., Nooney, J. & Evans, S. Recent concerns surround- Kloza, M., Makowska, U., Hiromatsu, Y. & Nauman, J. ing HRT: 145 Interleukin-13 gene polymorphisms in patients with Arnaldi, G. see Kola, B. Graves’ disease: 519 Arnhold, 1.J.P. see Carvalho, L.R van den Beld, A.W. see van Rossum, E.F.C. Arnold, A. see Shattuck, T.M. Bellanné-Chantelot, C. see Roussel, R. Arosio, M. see Giavoli, C. Bellastella, A. see De Bellis, A. 830 © 2003 Blackwell Publishing Ltd Clinical Endocrinology (2003) 59, 830-840 index Abalovich, M., Llesuy, S., Gutierrez, S. & Repetto, M. Peripheral Arp, P. see van Rossum, E.F.C. parameters of oxidative stress in Graves’ disease: the effects Arvat, E. see Gianotti, L. of methimazole and 131 iodine treatments: 321 Arvat, E. see Giordano, R. Adami, S. see Zoico, E. Asenbaum, S. see Zettinig, G. Agranovicz, S. see Krausz, Y. Assies, J., Haverkort, E.B., Lieverse, R. & Vreken, P. Effect of Agretti, P. see Tonacchera, M. dehydroepiandrosterone supplementation on fatty acid and Ahrén, B. see Biilow, B hormone levels in patients with X-linked adrenoleucodys- Aimaretti, G. see Popovic, V. trophy: 459 Aimaretti, G., Corneli, G., Baldelli, R., Di Somma, C., Astuti, D., Hart-Holden, N., Latif, F, Lalloo, F., Black, G.C., Gasco, V., Durante, C., Ausiello, L., Rovere, S., Grottoli, S., Lim, C., Moran, A., Grossman, A.B., Hodgson, S.V., Tamburrano, G. & Ghigo, E. Diagnostic reliability of a Freemont, A., Ramsden, R., Eng, C., Evans, D.G.R. & single IGF-I measurement in 237 adults with total anterior Maher, E.R. Genetic analysis of mitochondrial complex II hypopituitarism and severe GH deficiency: 56 subunits SDHD, SDHB and SDHC in paraganglioma and Akada, K. see Nishioka, H phaeochromocytoma susceptibility: 728 Alessi, E. see Verga, | Ausiello, L. see Aimaretti, G. Alevizaki, C.C. see Alevizaki, M Avila, A. see Bazaes, R.A. Alevizaki, M., Cimponeriu, A.T., Garofallaki, M., Sarika, H.-L., van Baar, A.L. see Pop, V.J Alevizaki, C.C., Papamichael, C., Philippou, G., Anastasiou, Badenhoop, K. & Seidl, C. Fine-tuning of T lymphocytes in E.A., Lekakis, J.P. & Mavrikakis, M. The androgen receptor autoimmunity: genetic association of CTLA-4 variants and gene CAG polymorphism is associated with the severity of Graves’ disease revisited: 555 coronary artery disease in men: 749 Balci, M.K. see Cakir, M. Altunbas, H. see Sari, R. Balci, M.K. see Sari, R Alvarez, P., Isidro, L., Peind, R., Leal-Cerro, A., Casanueva, F.F., Balci, N. see Cakir, M. Dieguez, C. & Cordido, F. Effect of acute reduction of free Baldelli, R. see Aimaretti, G. fatty acids by acipimox on growth hormone-releasing Baldelli, R., Battista, C., Leonetti, F, Ghiggi, M.-R., Ribaudo, hormone-induced GH secretion in type | diabetic patients M.-C., Paoloni, A., D’Amico, E., Ferretti, E., Baratta, R., 431 Liuzzi, A., Trischitta, V. & Tamburrano, G. Glucose home- Amato, G. see Mazziotti, G ostasis in acromegaly: effects of long-acting somatostatin Ambrogini, E. see Tonacchera, M. analogues treatment: 492 Anastasiou, E.A. see Alevizaki, M. Baratta, R. see Baldelli, R. de Andrés-Aguayo, I. see Webb, S.M Barbieri, F. see Florio, T. Antunes-Rodrigues, J. see Elias, P-C.L Bar-Shalom, R. see Krausz, Y Anyaoku, V. see Kousta, E. Battista, C. see Baldelli, R. Arai, K. see Kim, K Baudin, E. see Gussi, I.-L Arena, S. see Florio, T Bazaes, R.A., Petry, C.J., Ong, K.K., Avila, A., Dunger, D.B. & Arends, N.J.T., Boonstra, V.H., Mulder, P.G.H., Odink, R.J.H., Mericq, M.V. Insulin gene VNTR genotype is associated Stokvis-Brantsma, W.H., Rongen-Westerlaken, C., Mulder, with insulin sensitivity and secretion in infancy: 599 J.C., Delemarre-Van de Waal, H., Reeser, H.M., Jansen, M., Beckett, G.J. see Strachan, M.W.J. Waelkens, J.J.J. & Hokken-Koelega, A.C.S. GH treatment Beck-Peccoz, P. see Fugazzola, L. and its effect on bone mineral density, bone maturation and Beck-Peccoz, P. see Giavoli, C. growth in short children born small for gestational age: Beck-Peccoz, P. see Verga, U. 3-year results of a randomized, controlled GH trial: 779 Bednarczuk, T., Placha, G., Jazdzewski, K., Kurylowicz, A., Armitage, M., Nooney, J. & Evans, S. Recent concerns surround- Kloza, M., Makowska, U., Hiromatsu, Y. & Nauman, J. ing HRT: 145 Interleukin-13 gene polymorphisms in patients with Arnaldi, G. see Kola, B. Graves’ disease: 519 Arnhold, 1.J.P. see Carvalho, L.R van den Beld, A.W. see van Rossum, E.F.C. Arnold, A. see Shattuck, T.M. Bellanné-Chantelot, C. see Roussel, R. Arosio, M. see Giavoli, C. Bellastella, A. see De Bellis, A. 830 © 2003 Blackwell Publishing Ltd Author Index 831 de Bellis, A., Bizzarro, A., Conte, M., Coronella, C., Solimeno, Buzi, F. see Radetti, G. S., Perrino, S., Sansone, D., Guaglione, M., Wall, J.R. & Caiola, S. see Lucia, P. Bellastella, A. Relationship between longitudinal behaviour Cakir, M., Samanci, N., Balci, N. & Balci, M.K. Musculoskeletal of some markers of eye autoimmunity and changes in ocular manifestations in patients with thyroid disease: 162 findings in patients with Graves’ ophthalmopathy receiving Calderan, A. see Opocher, G. corticosteroid therapy: 388 Camargo-Neto, E. see Kreisner, E. Ben-Dov, I., Gaides, M., Scheinowitz, M., Wagner, R. & Cambiaghi, S. see Verga, U. Laron, Z. Reduced exercise capacity in untreated adults Cappiello, V. see Giavoli, C. with primary growth hormone resistance (Laron syndrome): Capuano, E. see Mazziotti, G. 763 Capuano, G. see Mattera, D. van Beneden, R. see Donckier, J.E. Capuano, S. see Mazziotti, G. Bengtsson, B.A. see Leonsson, M. Carbone, A. see Mazziotti, G. Ben-Shlomo, Y., Holly, J., McCarthy, A., Savage, P., Davies, D., Carella, C. see Mazziotti, G. Gunnell, D. & Smith, G.D. An investigation of fetal, post- Carroll, P.V. see Swords, F.M. natal and childhood growth with insulin-like growth factor Carvalho, L.R., de Faria, M.E.J., Farah Osorio, M.G., Estefan, V., I and binding protein 3 in adulthood: 366 Lima Jorge, A.A., Arnhold, I.J.P. & Mendonca, B.B. Acrome- Berselli, M.E. see Di Blasio, A.M. galic features in Growth hormore (GH)-deficient patients Bhatia, E. see Nigam, R. after long-term GH therapy: 788 Bidart, J.M. see Gussi, I.-L. Casamitjana, R. see Webb, S.M. Bifulco, G. see Tommaselli, G.A. Casanueva, FF. see Alvarez, P. Billadello, J.J. see Landt, M. Casanueva, F.F. see Popovic, V. Bissoli, L. see Zoico, E. Cassar, W. see Radetti, G. Bitti, M.L.M. see Tonacchera, M. Castagna, M.G. see Vermiglio, F. Bizzarro, A. see De Bellis, A. Castro, M. see Elias, P-C.L. Black, G.C. see Astuti, D. Castro, M., Elias, L.L.K., Elias, P.C.L. & Moreira, A.C. A Bocca, L. see Florio, T. dose-response study of salivary cortisol after dexametha- Bocher, M. see Krausz, Y. sone suppression test in Cushing’s disease and its potential Bogazzi, F. see Cecconi, E. use in the differential diagnosis of Cushing’s syndrome: 800 Boivin, C.M. see Shaw, N.J. Ceccarelli, C. see Tonacchera, M. Boonstra, V.H. see Arends, N.J.T. Cecconi, E., Bogazzi, F, Cetani, F, Grasso, L., Marcocci, C., Boscaro, M. see Kola, B. Genovesi, M., Procopio, M., Gasperi, M., Pinchera, A., Bosello, O. see Zoico, E Ghigo, E. & Martino, E. Impaired GH secretion to provoc- Boutignon, F. see Gianotti, L. ative stimuli in two families with hypocalciuric hypercal- Brabant, G. see Parkinson, C. caemia: 604 Bradley, C. see McMillan, C.V. Cela, E. see Kousta, E. van den Brink, C.E. see Vermeer, H. Celermajer, D.S. see Sader, M.A. Brinkmann, A.O. see van Rossum, E.F.C. Cetani, F. see Cecconi, E. Brixen, K. see Gravholt, C.H. Chaganti, R.S.K. see Shattuck, T.M. Brossa, P. see Giordano, R Chan, J.C.N. see Ma, Y.Q. Brouwers, E.P. see Pop, V.J. Chanson, P. see Gussi, I.-L. Brown, L. see Tomasi, P.A. Chiovato, L. see Tonacchera, M. Brozzetti, A. see Nigam, R. Chisin, R. see Krausz, Y. Bilow, B., Ahrén, B., Fisker, S., Dehlin, O., Hagberg, B., Christiansen, J.S. see Gravholt, C.H. Jensen, E., Svensson, T., Samuelsson, G. & Erfurth, E.M. Cimponeriu, A.T. see Alevizaki, M. The gender differences in growth hormone-binding protein Cirié, J. see Zarkovié, M. and leptin persist in 80-year-old men and women and is not Cittadini, A. see Sacca, L. caused by sex hormones: 482 Clark, O.H. see Shattuck, T.M. Buongiorno, A.M. see Lucia, P. Clark, P. see Weedon, M.N. van der Burg, B. see Vermeer, H. Clayton, P.-E. see Parkinson, C. van Buul-Offers, S.C. see Vermeer, H. Clayton, P.-E. see Whatmore, A.J. Bustin, S. see Kola, B. Cockram, C.S. see Ma, Y.Q. © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 830—840 832 Author Index Codoceo, R. see Iglesias, P. Donckier, J.E., Michel, L., Van Beneden, R., Delos, M. & Colantuoni, V. see Mancini, F.P. Havaux, X. Increased expression of endothelin-1 and its Colao, A. see Mattera, D mitogenic receptor ET, in human papillary thyroid carci- Columb, B. see Mukherjee, A noma: 354 Contaldo, F. see Mancini, FP. Don-Wauchope, A.C. see Strachan, M.W.J. Conte, M. see De Bellis, A. Drake, W.M. see Parkinson, C. Coppola, A. see Lucia, P. Dubois-Laforgue, D. see Roussel, R. Cordido, F. see Alvarez, P. Dudezak, R. see Zettinig, G. Corneli, G. see Aimaretti, G. Dunger, D. see Potau, N. Corneli, G. see Popovic, V. Dunger, D.B. see Bazaes, R.A. Coronella, C. see De Bellis, A Durante, C. see Aimaretti, G. Corsaro, A. see Florio, T Eisenbarth, G.S. see Nigam, R. Cortelazzi, D. see Verga, U. Elias, L.L.K. see Castro, M. Costa, J. see Shattuck, T.M Elias, L.L.K. see Elias, P-C.L. Crabtree, N.J. see Shaw, N.J Elias, P-C.L. see Castro, M Crawford, L. see McKenzie, J. Elias, P.C.L., Elias, L.L.K., Torres, N., Moreira, A.C., Cridland, J.C. see Johnstone, A.P. Antunes-Rodrigues, J. & Castro, M. Progressive decline Critchley, J.A.J.H. see Ma, Y.Q of vasopressin secretion in familial autosomal dominant Crown, A. see Levy, A neurohypophyseal diabetes insipidus presenting a novel Czirjak, S. see Kola, B mutation in the vasopressin-neurophysin II gene: 51 1 D’ Agostino, L. see Mattera, D Elisei, R. see Tonacchera, M D’ Amico, E. see Baldelli, R. Ellis, J.A. & Harrap, S.B. Tall stories: the devilish detail of Da Costa, C.R. see Johnstone, A.P. genetic association studies: 278 Dacie, J.E. see Kaltsas, G.A Elnecave, R.H. see Mainieri, A.S Damjanovic, S. see Popovic, V. Emoto, M. see Nagasaki, 1 Dan, S. see Lazar, I Endert, E. see Strieder, T.G.A Davies, D. see Ben-Shlomo, Y. Eng,C . see Astuti, D. Davies, J.S. see Pinto, L.P. Engel, A. see Krausz, Y. Deghenghi, R. see Gianotti, L Epaminonda, P. see Giavoli, C. Dehlin, O. see Biilow, B Erenpreiss, Y. see de Gouveia Brazao, C.A. Deiguez, C. see Popovic, V. Erfurth, E.M. see Biilow, B. Delemarre-Van de Waal, H. see Arends, N.J.1 Estefan, V. see Carvalho, L.R Delitala, G. see Tomasi, P.A Ester, W. see van Rossum, E.F.C Delos, M. see Donckier, J.I Evans, D G.R. see Astuti, D. Destefanis, S. see Gianotti, L Evans, L.M. see Pinto, L.P. Destefanis, S. see Giordano, R Evans, S. see Armitage, M. Di Blasio, A.M., van Rossum, E.F.C., Maestrini, S., Berselli, M.E., Even-Sapir, E. see Krausz, Y Tagliaferri, M., Podesta, F., Koper, J.W., Liuzzi, A. & Falorni, A. see Nigam, R. Lamberts, S.W.J. The relation between two polymorphisms Farah Osorio, M.G. see Carvalho, L.R. in the glucocorticoid receptor gene and body mass index, de Faria, M.E.J. see Carvalho, L.R. blood pressure and cholesterol in obese patients: 68 Fernandez Pérez, C. see Gonzalez Sanchez, J.L. Di Carlo, C. see Tommaselli, G.A Ferrante, E. see Giavoli, C Di Somma, C. see Aimaretti, G. Ferretti, E. see Baldelli, R. Di Spiezio Sardo, A. see Tommaselli, G.A Fidalgo, P.A. see Iglesias, P. Diana, F. see Florio, T. Finelli, C. see Mancini, F.P. Diaz-Cano, S. see Kola, B. Finocchiaro, M.D. see Vermiglio, F Dieguez, C. see Alvarez, P. Fisker, S. see Billow, B. Diemling, M. see Zettinig, G. Florio, T., Thellung, S., Corsaro, A., Bocca, L., Arena, S., Diez, J.J. see Iglesias, P. Pattarozzi, A., Villa, V., Massa, A., Diana, F., Schettini, D., Dohle, G.R. see de Gouveia Brazao, C.A Barbieri, F., Ravetti, J.L., Spaziante, R., Giusti, M. & Schettini, Doknic, M. see Popovic, V. G. Characterization of the intracellular mechanisms © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 830-840 Author Index 833 mediating somatostatin and lanreotide inhibition of DNA the hypothalamus-—pituitary—thyroi daxis in children with synthesis and growth hormone release from dispersed GH deficiency: when should we be concerned about the human GH-secreting pituitary adenoma cells in vitro: 115 occurrence of central hypothyroidism?: 806 Foy, P. see Malik, I.A. Gibney, J. see McMillan, C.V. Fraser, N.C. see Shaw, N.J. Giordano, R., Grottoli, S., Brossa, P., Pellegrino, M., Destefanis, Frayling, T.M. see Weedon, M.N. S., Lanfranco, F., Gianotti, L., Ghigo, E. & Arvat, E. Alpra- Freaney, R. see Suliman, A.M. zolam (a benzodiazepine activating GABA receptor) Freemont, A. see Astuti, D. reduces the neuroendocrine responses to insulin-induced Fueger, B.J. see Zettinig, G. hypoglycaemia in humans: 314 Fugazzola, L. see Verga, U. Giusti, M. see Florio, T. Fugazzola, L., Persani, L., Mannavola, D., Reschini, E., Vannuc- Gleeson, H.K. see Mukherjee, A. chi, G., Weber, G. & Beck-Peccoz, P. Recombinant human Gligorovié, PV. see Zarkovic, M. TSH testing is a valuable tool for differential diagnosis of Godsland, I.F. see Kousta, E. congenital hypothyroidism during L-thyroxine replacement: Gonzalez Sanchez, J.L., Proenza, A.M., Martinez Larrad, M.T., 230 Ramis, J.M., Fernandez Pérez, C., Palou, A. & Serrano Rios, Fujiwara, S. see Nagasaki, T. M. The glutamine 27 glutamic acid polymorphism of the Furuhashi, M., Ura, N., Higashiura, K., Murakami, H. & §,-adrenoceptor gene is associated with abdominal obesity Shimamoto, K. Circulating resistin levels in essential and greater risk of impaired glucose tolerance in men hypertension: 507 but not in women: a population-based study in Spain: Fuse, Y., Igari, T., Yamada, C., Sakano, S., Ito, H., Umenai, T. & 476 Irie, M. Epidemiological survey of thyroid volume and Gough, S.C.L. see Tait, K.F. iodine intake in schoolchildren, postpartum women and de Gouveia Brazao, C.A., Pierik, FH., Erenpreiss, Y., de Jong, neonates living in Ulaan Baatar: 298 FH., Dohle, G.R. & Weber, R.EA. The effect of cryp- Gai, V. see Tassone, F. torchidism on inhibin B in a subfertile population: 136 Gaides, M. see Ben-Dov, I. Granberg, D., Sundin, A., Janson, E.T., Oberg, K., Skogseid, B. Gallacher, S. see McKenzie, J. & Westlin, J.-E. Octreoscan in patients with bronchial Gallardo, E. see Webb, S.M. carcinoid tumours: 793 Gangi, E. see Verga, U. Grasso, L. see Cecconi, E. Garofallaki, M. see Alevizaki, M. Gravholt, C.H., Vestergaard, P., Hermann, A.P., Mosekilde, L., Gasco, V. see Aimaretti, G Brixen, K. & Christiansen, J.S. Increased fracture rates in Gasperi, M. see Cecconi, E. Turner’s syndrome: a nationwide questionnaire survey: 89 Gaz, R.D. see Shattuck, T.M. Greer, I.A. see McKenzie, J. Genovesi, M. see Cecconi, E. Griffiths, K.A. see Sader, M.A. Ghiggi, M.-R. see Baldelli, R. Grobbee, D.E. see van Rossum, E.F.C. Ghigo, IE . see Aimaretti, G. Gross, J.L. see Kreisner, E. Ghigo, IE . see Cecconi, E. Grossman, A.B. see Astuti, D. Ghigo, E. see Gianotti, L. Grossman, A.B. see Kaltsas, G.A. Ghigo, IE . see Giordano, R Grossman, A.B. see Kola, B. Ghigo, IE . see Popovic, V. Grottoli, S. see Aimaretti, G. Ghigo, IE . see Tassone, F. Grottoli, S. see Giordano, R. Gianotti, L. see Giordano, R. Grottoli, S. see Tassone, F. Gianotti, L. see Tassone, F. Guaglione, M. see De Bellis, A. Gianotti, L., Veldhuis, J.D., Destefanis, S., Lanfranco, F., Ram- Gunnell, D. see Ben-Shlomo, Y. unni, J., Arvat, E., Marzetto, M., Boutignon, F., Deghenghi, Gupta, N. see Marwaha, R.K. R. & Ghigo, E. Suppression and recovery of LH secretion Gurnell, M. PPARy and metabolism: insights from the study of by a potent and selective GnRH-receptor antagonist peptide human genetic variants: 267 in healthy early follicular-phase women are mediated via Gussi, I.-L., Young, J., Baudin, E., Bidart, J.M. & Chanson, P. selective control of LH secretory burst mass: 526 Chromogranin A as serum marker of pituitary adenomas: Giavoli, C., Porretti, S., Ferrante, E., Cappiello, V., Ronchi, C.L., 644 Travaglini, P., Epaminonda, P., Arosio, M. & Beck- Gutierrez, S. see Abalovich, M. Peccoz, P. Recombinant hGH replacement therapy and Hagberg, B. see Biilow, B. © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 830—840 834 Author Index Hall, C.M. see Whatmore, A.J. Jayasinghe, A. see Okosieme, O.E. Handelsman, D.J. see Sader, M.A. Jazdzewski, K. see Bednarczuk, T. Hanna, F.W.F. see Pinto, L-.P. Jensen, E. see Biilow, B. Hanson, J.A. see Kaltsas, G.A. Johannsson, G. see Leonsson, M. Harada, S. see Kotani, T. John, R. see Pinto, L.P. Haraoka, J. see Nishioka, H. Johnston, D.G. see Kousta, E. Harrap, S.B. see Ellis, J.A. Johnstone, A.P., Cridland, J.C., Da Costa, C.R., Nussey, S.S. & Hart-Holden, N. see Astuti, D. Shepherd, P.S. A functional site on the human TSH receptor: Hattersley, A.T. see Weedon, M.N. a potential therapeutic target in Graves’ disease: 437 Havaux, X. see Donckier, J.E. Jones, J. see Whatmore, A.J. Haverkort, E.B. see Assies, J. de Jong, FH. see de Gouveia Brazao, C.A. Hayakawa, T. see Tanaka, K. de Jong, FH. see van Rossum, E.F.C. Healy, M.L. see McMillan, C.V. Jonsson, P. see Lissett, C.A. Hendriks-Stegeman, B.I. see Vermeer, H. Jordan, S. see Kola, B. Henmi, Y. see Nagasaki, T. Kaltsas, G. see Kola, B. Hermann, A.P. see Gravholt, C.H. Kaltsas, G.A., Mukherjee, J.J., Kola, B., Isidori, A.M., Hanson, Higashiura, K. see Furuhashi, M J.A., Dacie, J.E., Reznek, R., Monson, J.P. & Grossman, Hiromatsu, Y. see Bednarczuk, T. A.B. Is ovarian and adrenal venous catheterization and Hishinuma, A. see Kotani, T. sampling helpful in the investigation of hyperandrogenic Ho, K.K.Y. see Nugent, A.G. women?: 34 Hodgson, S.V. see Astuti, D Karak, A.K. see Marwaha, R.K. Hofmann, A. see Zettinig, G Karayalcin, U. see Sari, R. Hokken-Koelega, A.C.S. see Arends, N.J.T. Kawano, J. see Kotani, T. Hollenberg, A. see Shattuck, T.M Keidar, Z. see Krausz, Y. Holly, J. see Ben-Shlomo, Y Kelly, A. see McKenzie, J. Hulthe, J. see Leonsson, M Kelnar, C.J.H. Growth hormone therapy for syndromic disorders: Ibafiez, L. see Potau, N. 12 leiri, T. see Kotani, T. Kemp, E.H., Metcalfe, R.A., Smith, K.A., Woodroofe, M.N., Igari, T. see Fuse, Y. Watson, P.F. & Weetman, A.P. Detection and localization of Iglesias, P., Fidalgo, PA., Codoceo, R. & Diez, J.J. Serum chemokine gene expression in autoimmune thyroid disease: concentrations of adipocytokines in patients with hyper- 207 thyroidism and hypothyroidism before and after control of Kilby, M.D. Thyroid hormones and fetal brain development: 280 thyroid function: 621 Kim, K., Sanno, N., Arai, K., Takano, K., Yasufuku-Takano, J., Illa, I. see Webb, S.M. Teramoto, A. & Shibasaki, T. Ghrelin mRNA and GH secre- Imanishi, Y. see Shattuck, T.M. tagogue receptor mRNA in human GH-producing pituitary Inaba, M. see Nagasaki, T. adenomas is affected by mutations in the subunit of G lorio, S. see Mazziotti, G protein: 630 Irie, M. see Fuse, Y. Kim, T.S. see Shattuck, T.M. Ishii, N. see Tanaka, K. Kisalu, J. see Swords, F.M. Ishikawa, T. see Nagasaki, T Kloza, M. see Bednarczuk, T. Ishimura, E. see Nagasaki, T. Knight, B. see Weedon, M.N Isidori, A.M. see Kaltsas, G.A Kochupillai, N. see Marwaha, R.K. Isidro, L. see Alvarez, P. Kogan, I. see Krausz, Y. Israel, O. see Krausz, Y Kola, B. see Kaltsas, G.A. Ito, H. see Fuse, Y Kola, B., Korbonits, M., Diaz-Cano, S., Kaltsas, G., Morris, Ivovic, M.S. see Zarkovic, M. D.G., Jordan, S., Metherell, L., Powell, M., Czirjak, S., Jaap, A.J. see McKenzie, J. Arnaldi, G., Bustin, S., Boscaro, M., Mantero, F. & Gross- Jansen, M. see Arends, N.J.T. man, A.B. Reduced expression of the growth hormone and Jansen, M. see Vermeer, H. type | insulin-like growth factor receptors in human soma- Janson, E.T. see Granberg, D. totroph tumours and an analysis of possible mutations of Janssen, J.A.M.J.L. see van Rossum, E.F.C the growth hormone receptor: 328 © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 830-840 Author Index 835 Koper, J.W. see Di Blasio, A.M. independently related to their carotid intima-media thick- Koper, J.W. see van Rossum, E.F.C. ness: 242 Korbonits, M. see Kola, B. Leung, K.-C. see Nugent, A.G. Kosti¢, V. see Zarkovié, M. Levy, A., Crown, A. & Reid, R. Endocrine intervention for trans- Kotani, T., Umeki, K., Kawano, J—., Suganuma, T., Hishinuma, sexuals: 409 A., leiri, T. & Harada, S. Partial iodide organification defect Lieverse, R. see Assies, J. caused by a novel mutation of the thyroid peroxidase gene Lim, C. see Astuti, D. in three siblings: 198 Lim, P.O. & MacDonald, T.M. Primary aldosteronism, diagnosed Kousta, E., Lawrence, N.J., Godsland, I.F., Penny, A., Anyaoku, by the aldosterone to renin ratio, is a common cause of V., Millauer, B.A., Cela, E., Johnston, D.G., Robinson, S. hypertension: 427 & McCarthy, M.I. Insulin resistance and B-cell dysfunction Lima Jorge, A.A. see Carvalho, L.R. in normoglycaemic European women with a history of Lissett, C.A., Jonsson, P., Monson, J.P. & Shalet, S.M. Determin- gestational diabetes: 289 ants of IGF-I statusin a large cohort of growth hormone- Krausz, Y., Keidar, Z., Kogan, I., Even-Sapir, E., Bar-Shalom, deficient (GHD) subjects: the role of timing of onset of R., Engel, A., Rubinstein, R., Sachs, J., Bocher, M., GHD: 773 Agranovicz, S., Chisin, R. & Israel, O. SPECT/CT hybrid Liuzzi, A. see Baldelli, R. imaging with ' In-pentetreotide in assessment of neuroen- Liuzzi, A. see Di Blasio, A.M. docrine tumours: 565 Llesuy, S. see Abalovich, M. Kreisner, E., Camargo-Neto, E., Maia, C.R. & Gross, J.L. Lo Presti, V.P. see Vermiglio, F. Accuracy of ultrasonography to establish the diagnosis and Lo, C.Y. see Tso, A.W.K. aetiology of permanent primary congenital hypothyroidism: Lowe, G.D. see McKenzie, J. 361 Lucia, P., Caiola, S., Coppola, A., Manetti, L.L., Maroccia, E., Kribben, A. see Witzke, O. Buongiorno, A.M. & de Martinis, C. Vasoactive intestinal Krohn, K. see Miedlich, S. peptide (VIP): a new neuroendocrine marker of clinical Kumeda, Y. see Nagasaki, T. progression in chronic heart failure?: 723 Kurylowicz, A. see Bednarczuk, T. Ludbrook, P.A. see Landt, M. Lalloo, F. see Astuti, D. Ma, Y.Q., Thomas, G.N., Ng, M.C.Y., Critchley, J.A.J.H., Lam, K.S.L. see Tan, K.C.B. Cockram, C.S., Chan, J.C.N. & Tomlinson, B. Association Lam, K.S.L. see Tso, A.W.K. of two apolipoprotein A-I gene MspI polymorphisms Lamberts, S.W.J. see Di Blasio, A.M. with high density lipoprotein (HDL)-cholesterol levels and Lamberts, S.W.J. see van Rossum, E.F.C. indices of obesity in selected healthy Chinese subjects and Landt, M., Ludbrook, P.A. & Billadello, J.J. Role of protein bind- in patients with early-onset type 2 diabetes: 442 ing in renal elimination of leptin: 44 Maccario, M. see Tassone, F. Lanfranco, F. see Gianotti, L. MacDonald, T.M. see Lim, P.O. Lanfranco, F. see Giordano, R. MacFarlane, I.A. see Malik, I.A. Lanfranco, F. see Tassone, F. Macut, D. see Zarkovic, M. Laron, Z. see Ben-Dov, I. Maestrini, S. see Di Blasio, A.M. Larsson, C. see Tso, A.W.K. Maghnie, M. see Radetti, G. Latif, F. see Astuti, D. Maher, E.R. see Astuti, D. Lawrence, N.J. see Kousta, E. Maia, C.R. see Kreisner, E. Lazar, L., Dan, S. & Phillip, M. Growth without growth hor- Mainieri, A.S. & Elnecave, R.H. Usefulness of the free a-subunit mone: growth pattern and final height of five patients with to diagnose hypogonadotropic hypogonadism: 307 idiopathic combined pituitary hormone deficiency: 82 Makowska, U. see Bednarczuk, T. Lazarus, J.H. see Okosieme, O.E. Malik, I.A., Foy, P., Wallymahmed, M., Wilding, J.PH. & Leal-Cerro, A. see Alvarez, P. Macfarlane, I.A. Assessment of quality of life in adults re- Lejeune, P.J. see Okosieme, O.E. ceiving long-term growth hormone replacement compared Lekakis, J.P. see Alevizaki, M. to control subjects: 75 Leonetti, F. see Baldelli, R. Mancini, F.P., Sabatino, L., Colantuoni, V., Pasanisi, F., Finelli, C., Leonsson, M., Hulthe, J., Johannsson, G., Wiklund, O., Contaldo, F., Masulli, M., Riccardi, G. & Vaccaro, O. Wikstrand, J., Bengtsson, B.A. & Oscarsson, J. Increased Variants of uncoupling protein-2gene and obesity: interac- Interleukin-6 levels in pituitary-deficient patients are tion with peroxisome proliferator-activated receptory2: 817 © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 830—840 836 Author Index Mandolfino, M. see Vermiglio, F Michel, L. see Donckier, J.E. Manetti, L.L. see Lucia, P. Micic, D. see Popovic, V. Manguso, F. see Mattera, D. Miedlich, S., Krohn, K. & Paschke, R. Update on genetic and Mann, K. see Witzke, O. clinical aspects of primary hyperparathyroidism: 539 Mannavola, D. see Fugazzola, L. Millauer, B.A. see Kousta, E. Mantero, F. see Kola, B. Mittlboeck, M. see Zettinig, G. Mantero, F. see Opocher, G. Mizuguchi, H. see Tanaka, K. de Marco, G. see Tonacchera, M. Moleti, M. see Vermiglio, F. Marcocci, C. see Cecconi, E. Monchik, J.M. see Shattuck, T.M Maroccia, E. see Lucia, P. Monson, J.P. see Kaltsas, G.A. Martinez Larrad, M.T. see Gonzalez Sanchez, J.L. Monson, J.P. see Lissett, C.A. Martella, M. see Opocher, G. Monson, J.P. see Swords, F.M. de Martinis, C. see Lucia, P. Moran, A. see Astuti, D. Martino, E. see Cecconi, E. Moreira, A.C. see Castro, M. Marwaha, R.K., Tandon, N., Gupta, N., Karak, A.K., Verma, K. & Moreira, A.C. see Elias, P.C.L. Kochupillai, N. Residual goitre in the postiodization phase: Morris, D.G. see Kola, B. iodine status, thiocyanate exposure and autoimmunity: 672 Mosekilde, L. see Gravholt, C.H. Marzetto, M. see Gianotti, L Mostacciuolo, M.L. see Opocher, G. Massa, A. see Florio, T. Mukherjee, A., Murray, R.D., Columb, B., Gleeson, H.K. & Masulli, M. see Mancini, F.P. Shalet, S.M. Acquired prolactin deficiency indicates severe Mattera, D., Capuano, G., Colao, A., Pivonello, R., Manguso, F., hypopituitarism in patients with disease of the hypothalamic Puzziello, A. & D’ Agostino, L. Increased IGF-I : IGFBP-3 pituitary axis: 743 ratio in patients with hepatocellular carcinoma: 699 Mukherjee, J.J. see Kaltsas, G.A. Mattina, F. see Vermiglio, F. Mulder, J.C. see Arends, N.J.T. Mavrikakis, M. see Alevizaki, M Mulder, P.G.H. see Arends, N.J.T. Mazzali, G. see Zoico, E. Murakami, H. see Furuhashi, M Mazziotti, G., Sorvillo, F., lorio, S., Carbone, A., Romeo, A., Muranaga, T. see Tanaka, M. Piscopo, M., Capuano, S., Capuano, E., Amato,G . & Carella, Murgia, A. see Opocher, G. C. Grey-scale analysis allows a quantitative evaluation of Murray, B. see Suliman, A.M. thyroid echogenicity in the patients with Hashimoto’s Murray, R.D. see Mukherjee, A. thyroiditis: 223 Nagasaki, T., Inaba, M., Henmi, Y. , Kumeda, Y., Ueda, M., McBrinn, Y. see Suliman, A.M. Tahara, H., Sugiguchi, S., Fujiwara, S., Emoto, M., McCarthy, A. see Ben-Shlomo, Y. Ishimura, E., Onoda, N., Ishikawa, T. & Nishizawa, Y. McCarthy, M.I. see Kousta, E. Decrease in carotid intima-media thickness in hypothyroid McKenna, T.J. see Suliman, A.M. patients after normalization of thyroid function: 607 McKenzie, J., Jaap, A.J., Gallacher, S., Kelly, A., Crawford, L., Nagayama, Y. see Tanaka, K Greer, I.A., Rumley, A., Petrie, J.R., Lowe, G.D., Paterson, K. Nakahara, T. see Tanaka, M. & Sattar, N. Metabolic, inflammatory and haemostatic Nakao, K. see Tanaka, K effects of a low-dose continuous combined HRT in women Nakazato, M. see Tanaka, M. with type 2 diabetes: potentially safer with respect to vascular Napoli, R. see Sacca, I risk?: 682 Nappi, C. see Tommaselli, G.A. McMillan, C.V., Bradley, C., Gibney, J., Healy, M.L., Russell- Naruo, T. see Tanaka, M. Jones, D.L. & Sénksen, P.H. Psychological effects of Nauman, J. see Bednarczuk, T withdrawal of growth hormone therapy from adults with Navone, F. see Tassone, F. growth hormone deficiency: 467 Ng, M.C.Y. see Ma, Y.Q. Mendonca, B.B. see Carvalho, L.R. Nigam, R., Bhatia, E., Miao, D., Yu, L., Brozzetti, A., Eisenbarth, Mericq, M.V. see Bazaes, R.A. G.S. & Falorni, A. Prevalence of adrenal antibodies in Mestron, A. see Webb, S.M. Addison’s disease among north Indian Caucasians: 593 Metcalfe, R.A. see Kemp, E.H. Nishioka, H., Haraoka, J. & Akada, K. Fibrous bodies are Metherell, L. see Kola, B. associated with lower GH production and decreased expres- Miao, D. see Nigam, R. sion of E-cadherinin GH-producing pituitary adenomas: 768 © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 830—840 Author Index 837 Nishizawa, Y. see Nagasaki, T. Pekic, S. see Popovic, V. Niwa, M. see Tanaka, K. Pellegrino, M. see Giordano, R. Nooney, J. see Armitage, M. Pellicano, M. see Tommaselli, G.A. Nozoe, S.-I. see Tanaka, M. Penezi¢, Z. see Zarkovi¢, M Nugent, A.G., Leung, K.-C., Sullivan, D., Reutens, A.T. & Penny, A. see Kousta, E. Ho, K.K.Y. Modulation by progestogens of the effects of Perri, A. see Tonacchera, M. oestrogen on hepatic endocrine function in postmenopau- Perrino, S. see De Bellis, A. salwomen: 690 Persani, L. see Fugazzola, L. Nussey, S.S. see Johnstone, A.P. Petrie, J.R. see McKenzie, J. Oates, R. see Tomasi, P.A. Petry, C.J. see Bazaes, R.A. Oberg, K. see Granberg, D. Philipp, T. see Witzke, O. Odink, R.J.H. see Arends, N.J.T. Philippou, G. see Alevizaki, M. Okosieme, O.E., Premawardhana, L.D.K.E., Jayasinghe, A., de Phillip, M. see Lazar, L. Silva, D.G.H., Smyth, PP.A., Parkes, A.B., Lejeune, P.J., Pierik, FH. see de Gouveia Brazao, C.A. Ruf, J. & Lazarus, J.H. Thyroglobulin epitope recognition Pinchera, A. see Cecconi, E. in a post iodine-supplemented Sri Lankan population: Pinchera, A. see Tonacchera, M. 190 Pinto, L.P., Hanna, F.W.F., Evans, L.M., Davies, J.S., John, R. & Ong, K. see Potau, N. Scanlon, M.F. The TSH response to domperidone reflects Ong, K.K. see Bazaes, R.A. the biological activity of prolactin in macroprolactinaemia Onoda, N. see Nagasaki, T. and hyperprolactinaemia: 580 Opocher, G., Schiavi, F., Vettori, A., Pampinella, F., Vitiello, L., Piscopo, M. see Mazziotti, G. Calderan, A., Vianello, B., Murgia, A., Martella, M., Tac- Pivetti, S. see Tassone, F. caliti, A., Mantero, F. & Mostacciuolo, M.L. Fine analysis Pivonello, R. see Mattera, D. of the short arm of chromosome | in sporadic and familial Placha, G. see Bednarezuk, T. pheochromocytoma: 707 Plehwe, W.E. Vitamin D deficiency in the 21st century: an un- Ortega, E. see Webb, S.M. necessary pandemic?: 22 Oscarsson, J. see Leonsson, M. Podesta, F. see Di Blasio, A.M. Padfield, P.L. Prevalence and role of a raised aldosterone to renin Pols, H.A.P. see van Rossum, E.E.C. ratio in the diagnosis of primary aldosteronism: a debate Pop, V.J., Brouwers, E.P., Vader, H.L., Vulsma, T., van Baar, A.L. on the scientific logic of the use of the ratio in practice: & de Vijlder, J.J. Maternal hypothyroxinaemia during early 422 pregnancy and subsequent child development: a 3-year Paganini, C. see Radetti, G. follow-up study: 282 Page, D.C. see Tomasi, P.A. Popovic, V., Pekic, S., Doknic, M., Micic, D., Damjanovic, S., Palanisamy, N. see Shattuck, T.M. Zarkovic, M., Aimaretti, G., Corneli, G., Ghigo, E., Palou, A. see Gonzalez Sanchez, J.L. Deiguez, C. & Casanueva, FF The effectiveness of Pampinella, F. see Opocher, G. arginine + GHRH test compared with GHRH + GHRP-6 Pang, R.W.C. see Tan, K.C.B. test in diagnosing growth hormone deficiency in adults: Panunzi, C. see Tonacchera, M. 251 Paoloni, A. see Baldelli, R. Porretti, S. see Giavoli, C. Papamichael, C. see Alevizaki, M. Potau, N., Williams, R., Ong, K., Sanchez-Ufarte, C., de Zegher, F., Parkes, A.B. see Okosieme, O.E. Ibanez, L. & Dunger, D. Fasting insulin sensitivity and Parkinson, C., Whatmore, A.J., Yates, A.P., Drake, W.M., Brabant, post-oral glucose hyperinsulinaemia related to cardio- G., Clayton, PE. & Trainer, P.J. The effect of pegvisomant- vascular risk factors in adolescents with precocious induced serum IGF-I normalization on serum leptin levels pubarche: 756 in patients with acromegaly: 168 Powell, M. see Kola, B. Pasanisi, F. see Mancini, FP. Premawardhana, L.D.K.E. see Okosieme, O.E. Paschke, R. see Miedlich, S. Pritelli, C. see Verga, U. Paterson, K. see McKenzie, J. Procopio, M. see Cecconi, E. Pattarozzi, A. see Florio, T. Proenza, A.M. see Gonzalez Sanchez, J.L. Pearce, S.H.S. see Sayer, J.A. Prummel, M.F. see Strieder, T.G.A. Peino, R. see Alvarez, P. Puzziello, A. see Mattera, D. © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 830—840 838 Author Index Radetti, G., Buzi, F., Cassar, W., Paganini, C., Stacul, E. & Sagiyama, K.-I. see Tanaka, M. Maghnie, M. Growth hormone secretory pattern and re- Sakano, S. see Fuse, Y. sponse to treatment in children with short stature followed Samanci, N. see Cakir, M. to adult height: 27 Samuelsson, G. see Biilow, B. Ramis, J.M. see Gonzalez Sanchez, J.L Sanchez-Ufarte, C. see Potau, N. Ramsden, R. see Astuti, D. Sanno, N. see Kim, K. Ramunni, J. see Gianotti, L. Sansone, D. see De Bellis, A. Ravetti, J.L. see Florio, T. Sari, R., Balci, M.K., Altunbas, H. & Karayalcin, U. The effect Reeser, H.M. see Arends, N.J.T. of body weight and weight loss on thyroid volume and func- Refetoff, S. see Tonacchera, M. tion in obese women: 258 Reid, R. see Levy, A. Sarika, H.-L. see Alevizaki, M. Reinhardt, W. see Witzke, O Sattar, N. see McKenzie, J. Reis, A.F. see Roussel, R Savage, P. see Ben-Shlomo, Y. Repetto, M. see Abalovich, M. Sayer, J.A. & Pearce, S.H.S. Extracellular calcium-sensing recep- Reschini, E. see Fugazzola, L. tor dysfunction is associated with two new phenotypes: 419 Reutens, A.T. see Nugent, A.G. Scanlon, M.F. see Pinto, L.P. Reznek, R. see Kaltsas, G.A. Scheinowitz, M. see Ben-Dov, I Ribaudo, M.-C. see Baldelli, R. Schettini, D. see Florio, T. Riccardi, G. see Mancini, F.P. Schettini, G. see Florio, T. Robinson, S. see Kousta, E. Schiavi, F. see Opocher, G. Rojas-Garcia, R. see Webb, S.M. Seidl, C. see Badenhoop, K Romeo, A. see Mazziotti, G Serrano Rios, M. see Gonzalez Sanchez, J.L. Ronchi, C.L. see Giavoli, C Serrano-Munuera, C. see Webb, S.M. Rong, R. see Tso, A.W.K. de Servi, M. see Tonacchera, M. Rongen-Westerlaken, C. see Arends, N.J.T. Seth, J. see Strachan, M.W.J. Rose, S. see Shaw, N.J. Shalet, S.M. see Lissett, C.A. Rossetto, R. see Tassone, F Shalet, S.M. see Mukherjee, A van Rossum, E.F.C. see Di Blasio, A.M. Shattuck, T.M., Kim, T.S., Costa, J., Yandell, D.W., Imanishi, Y., van Rossum, E.F.C., Koper, J.W., van den Beld, A.W., Uitter- Palanisamy, N., Gaz, R.D., Shoback, D., Clark, O.H.., linden, A.G., Arp, P., Ester, W., Janssen, J.A.M.J.L., Brink- Monchik, J.M., Wierman, M.E., Hollenberg, A., Tojo, K.., mann, A.O., de Jong, FH., Grobbee, D.E., Pols, H.A.P. & Chaganti, R.S.K. & Arnold, A. Mutational analyses of RB Lamberts, S.W.J. Identification of the Bc/l polymorphism in and BRCA2 as candidate tumour suppressor genes in the glucocorticoid receptor gene: association with sen- parathyroid carcinoma: 180 sitivity to glucocorticoids in vivo and body mass index: 585 Shaw, N.J., Fraser, N.C., Rose, S., Crabtree, N.J. & Boivin, C.M. Roussel, R., Reis, A.F., Dubois-Laforgue, D., Bellanné- Bone density and body composition in children with growth Chantelot, C., Timsit, J. & Velho, G. The N363S polymorphism hormone insensitivity syndrome receiving recombinant in the glucocorticoid receptor gene is associated with over- IGF-I: 487 weight in subjects with type 2 diabetes mellitus: 237= Shepherd, P.S. see Johnstone, A.P. Rovere, S. see Aimaretti, G. Shibasaki, T. see Kim, K. Rubinstein, R. see Krausz, Y Shimamoto, K. see Furuhashi, M Ruf, J. see Okosieme, O.E. Shoback, D. see Shattuck, T.M Rumley, A. see McKenzie, J de Silva, D.G.H. see Okosieme, O.E. Russell-Jones, D.L. see McMillan, C.V. Skilton, M.R. see Sader, M.A. van der Saag, P.T. see Vermeer, H. Skogseid, B. see Granberg, D. Sabatino, L. see Mancini, FP. Smith, G.D. see Ben-Shlomo, Y. Sacca, L., Napoli, R. & Cittadini, A. Growth hormone, acrome- Smith, K.A. see Kemp, E.H galy, and heart failure: an intricate triangulation: 660 Smith, T.P. see Suliman, A.M. Sachs, J. see Krausz, Y Smyth, P.P.A. see Okosieme, O.E. Sader, M.A., Griffiths, K.A., Skilton, M.R., Wishart, S.M., Han- Solimeno, S. see De Bellis, A. delsman, D.J. & Celermajer, D.S. Physiological testosterone Sonksen, P.H. see McMillan, C.V. replacement and arterial endothelial function in men: 62 Sorvillo, F. see Mazziotti, G © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 830—840